Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
10/2011
10/20/2011US20110256056 Monoclonal Antibodies Against HER2 Antigens, and Uses Therefor
10/20/2011CA2793451A1 Aptamers to .beta.-ngf and their use in treating .beta.-ngf mediated diseases and disorders
10/19/2011EP2377873A1 RNAi modulation of ApoB and uses thereof
10/19/2011EP2377555A2 Antibodies against vascular endothelial growth factor receptor-1
10/19/2011EP2376641A1 Methods of modulating the sex of avians
10/19/2011EP2376619A1 Methods for control of flux in metabolic pathways
10/19/2011EP2376518A1 A complex and method for enhancing nuclear delivery
10/19/2011EP2376517A1 Transposon end compositions and methods for modifying nucleic acids
10/19/2011EP2376516A1 Bis-modified bicyclic nucleic acid analogs
10/19/2011EP2376514A2 Nucleoside analogs
10/19/2011EP2376449A1 Triaryl-sulphonium compounds, kit and methods for labeling positron emitting isotopes
10/19/2011EP2376087A1 Erbb-3 (her3)-selective combination therapy
10/19/2011EP2221377B1 Oligonucleotide compositions with enhanced efficiency
10/19/2011CN102223886A Erbb-3 (her3)-selective combination therapy
10/19/2011CN102219819A Nucleotide monomer capable of improving Tm value of oligonucleotide chain as well as preparation method and application thereof
10/18/2011US8039689 Plant farnesyltransferases
10/18/2011US8039688 Geminivirus resistant transgenic plants
10/18/2011US8039613 Methods of purifying a nucleic acid and formulation and kit for use in performing such methods
10/18/2011US8039612 Synthesis of oligonucleotides or phosphorothioate oligonucleotide with a capping agent of N-methylimidazole free of 1,3,5-trimethylhexahydro-1,3,5-triazine
10/18/2011US8039611 2′-hydroxyl group-modified ribonucleoside derivatives
10/18/2011US8039610 siRNA targeting superoxide dismutase 1 (SOD1)
10/18/2011US8039609 Aptamers directed to MUC1
10/18/2011US8039608 Bioinformatically detectable group of novel regulatory genes and uses thereof
10/18/2011US8039607 Probe, probe set, probe carrier, and testing method
10/18/2011US8039605 Targeting of long chain triacylglycerol hydrolase gene for tuberculosis treatment
10/18/2011US8039604 DNA sequence encoding penicillin acylase, novel recombinant recombinant DNA constructs and recombinant microorganisms
10/18/2011US8039603 Nucleic acid and corresponding protein entitled 121P1F1 useful in treatment and detection of cancer
10/18/2011US8039602 Nucleotide sequences coding polypeptide for use in the diagnosis treatment and prevention of tumors
10/18/2011US8039587 Recombinant high mobility polypeptide comprisingprotein transduction domain linked to non-nuclear organelle targeting signal; gene transfer vector
10/18/2011US8039446 Compounds for the modulation of beta-catenin expression
10/18/2011US8039443 polynucleotides that bind to proteins that regulate cell growth and division; used as antitumor agents alone or in combination with known cytotoxic agents
10/18/2011US8039261 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
10/18/2011US8039243 Insertion sequence-free bacteria
10/18/2011US8039241 Thermostable alpha-amylases
10/18/2011US8039237 Bioabsorbable polymer containing 2-hydroxyacid monomers
10/18/2011US8039236 Process for producing dipeptides
10/18/2011US8039234 Methods, panels of identification markers, and kits for identifying forensic samples
10/18/2011US8039232 Method for producing a dipeptide
10/18/2011US8039230 Selection of host cells expressing protein at high levels
10/18/2011US8039216 Methods for detecting nucleic acids using multiple signals
10/18/2011US8039213 Methods for assessing efficacy of chemotherapeutic agents
10/18/2011US8039007 Polypeptides from Neisseria meningitidis
10/18/2011US8039005 Mutant forms of streptolysin O
10/18/2011US8039003 Recombinant attenuated dengue viruses comprising a deletion in the 3′ untranslated region and additional attenuating mutations induced by chemical mutagenesis
10/18/2011US8039000 Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer
10/18/2011CA2506329C Candida kefyr cytosine deaminase
10/18/2011CA2463905C Method for formulating a glucose oxidase enzyme with a desired property or properties and a glucose oxidase enzyme with the desired property
10/18/2011CA2232237C Reagents and methods useful for detecting diseases of the breast
10/18/2011CA2228944C Liposomal phosphodiester, phosphorothioate, and p-ethoxy oligonucleotides
10/18/2011CA2176266C Detectably labeled dual conformation oligonucleotide probes, assays and kits
10/13/2011WO2011127180A1 Compositions and methods for inhibiting expression of cd274/pd-l1 gene
10/13/2011WO2011127174A1 Strains of xenotropic murine leukemia-related virus and methods for detection thereof
10/13/2011WO2011126974A1 Novel single chemical entities and methods for delivery of oligonucleotides
10/13/2011WO2011126937A1 Targeted intracellular delivery of oligonucleotides via conjugation with small molecule ligands
10/13/2011WO2011126804A1 Uses of chec peptides to treat neurological and cardiovascular diseases and disorders
10/13/2011WO2011125943A1 Modified oligonucleotide
10/13/2011WO2011097420A3 Selection and characterization of dna aptamers with binding selectivity to campylobacter jejuni using whole-cell selex
10/13/2011WO2011012316A3 Rna with a combination of unmodified and modified nucleotides for protein expression
10/13/2011US20110252510 Soybean Plant and Seed Corresponding to Transgenic Event MON87754 and Methods for Detection Thereof
10/13/2011US20110252509 Method for Producing a Transgenic Cell with Increased Gamma-Aminobutyric Acid (Gaba) Content
10/13/2011US20110252504 Promoter From Z. Mais
10/13/2011US20110252491 Chimeric plant promoters and their uses in plants
10/13/2011US20110252488 Method of Identifying Genes which Promote Hybrid Vigour and Hybrid Debility and Uses Thereof
10/13/2011US20110251983 Methods for the survey and genetic analysis of populations
10/13/2011US20110251382 Isolation of nucleic acid
10/13/2011US20110251363 Stereoregular romp polymers
10/13/2011US20110251266 Aptamer for ngf and use thereof
10/13/2011US20110251264 Transcription factor decoys
10/13/2011US20110251263 RNAi Modulation of the BCR-ABL Fusion Gene and Uses Thereof
10/13/2011US20110251262 Compositions And Methods For Inhibiting Expression Of An RNA From West Nile Virus
10/13/2011US20110251261 Compositions and methods for inhibition of nucleic acids function
10/13/2011US20110251260 NOVEL siRNAS AND METHODS OF USE THEREOF
10/13/2011US20110251259 Compositions and methods for inhibiting expression of cd274/pd-l1 gene
10/13/2011US20110251258 Rnai constructs and uses thereof
10/13/2011US20110251140 Peptide antagonist of interleukin-15 activity
10/13/2011US20110251130 Methods and Compositions for Promoting Bone Growth
10/13/2011US20110251109 Fluidic methods for devices for parallel chemical reactions
10/13/2011US20110251108 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
10/13/2011US20110251107 G-quadruplex binding assays and compounds therefor
10/13/2011US20110251106 Pvii phage display
10/13/2011US20110251101 Combinatorial decoding of random nucleic acid arrays
10/13/2011US20110251098 Biomarkers in Peripheral Blood Mononuclear Cells for Diagnosing or Detecting Lung Cancers
10/13/2011US20110251090 Pancreatic cancer related gene ttll4
10/13/2011US20110251089 Methods for synthesis of encoded libraries
10/13/2011US20110250698 Methods of nucleic acid target capture
10/13/2011US20110250697 Non-naturally occurring dna sequences
10/13/2011US20110250683 Thermophilic and thermoacidophilic sugar transporter genes and enzymes from alicyclobacillus acidocaldarius and related organisms, methods
10/13/2011US20110250681 Fc Variants with Optimized Properties
10/13/2011US20110250672 Mutant dna polymerases and uses therof
10/13/2011US20110250671 Glucose dehydrogenase and method for producing the dehydrogenase
10/13/2011US20110250670 Light energy-induced stability of biomaterials
10/13/2011US20110250666 Short chain volatile hydrocarbon production using genetically engineered microalgae, cyanobacteria or bacteria
10/13/2011US20110250655 Biocatalysts For Manufacturing Duloxetine Alcohol
10/13/2011US20110250649 Pcr-based method of synthesizing a nucleic acid molecule
10/13/2011US20110250639 Methods for producing soluble membrane-spanning proteins
10/13/2011US20110250636 Novel gene GMS 01
10/13/2011US20110250631 Proteoglycan degrading mutants for treatment of cns
10/13/2011US20110250630 Motif-grafted hybrid polypeptides and uses thereof
10/13/2011US20110250628 Hcv replicons containing ns5b from genotype 2b
10/13/2011US20110250608 Use of ultraconserved rna in detection and treatment of cancer